Associate Professor Stephen Stranks is Director of Southern Adelaide Diabetes and Endocrine Services and Associate Professor at Flinders University of South Australia. His clinical role involves delivery of services in Diabetes, Endocrinology and Metabolic Bone Disease at Flinders Medical Centre, Repatriation General Hospital and Noarlunga Hospital and public outreach services in community settings in the region. His major personal interests are in postgraduate training and clinical trials in diabetes management in outpatient and inpatient settings. He leads a clinical research team based at RGH and provides diabetes and metabolic input to Flinders Cardiac Research and the Flinders Clinical Trial Centre. He has been an ADS representative on the Endocrinology Specialist Advisory Committee for the past 4 years. (Director Disclosures - PDF)
Associate Professor Anthony Russell (MBBS PhD FRACP) is Director of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane. He has a conjoint appointment as A/Professor of Medicine with the University of Queensland. A/Prof Russell has completed a 4 year term as Co-Chair of the Qld Statewide Diabetes Clinical Network and in this role has provided advice and implemented strategies to assist in the management of patients with diabetes. A/Professor Russell has lead innovative projects to provide new models of care for people with diabetes. He has implemented the “Beacon” practice model, providing integrated care for patients with complex Type 2 diabetes in the community with up-skilled GPs. He has initiated a Telehealth service, delivering diabetes services to rural and remote indigenous and non-indigenous communities across Qld. A/Prof Russell has been on the advisory group for the “IDEAS” project which has increased rates of retinal screening and treatment of retinopathy in indigenous people with diabetes across QLD. A/Professor Russell is a Chief Investigator on two NHMRC research projects. He has been Chair of the Diabetes Australia Research Trust grant review panel and is currently Sub-editor (Endocrinology) for the Internal Medicine Journal. A/Prof Russell was on the expert advisory group for the NHMRC guidelines on the Management of Type 1 diabetes and a member of the Expert Group for Therapeutic Guidelines: Endocrinology versions 4 and 5. (Director Disclosures - PDF)
Professor Jonathan Shaw underwent his clinical and research training in the UK. At Melbourne’s Baker IDI Heart and Diabetes Institute, he runs a large research section focussing on epidemiology and clinical research in diabetes, and is also a consultant physician in the diabetes services. He has authored over 350 peer-reviewed scientific papers and 35 book chapters. He is the Chair of the National Diabetes Data Working Group, Past-President of the International Diabetes Epidemiology Group, was awarded the global Novartis Diabetes Award (for research) in 2006, and in 2011 was awarded the International Diabetes Epidemiology Group Peter Bennett award. In 2014, he was included in the Thomson Reuters The World’s Most Influential Scientific Minds, which lists the 1% most highly cited scientists in the world since 2002. In 2015, he was awarded the Australian Diabetes Society's Jeff Flack Diabetes Data Award.
Associate Professor Spiros Fourlanos is a Consultant Endocrinologist and General Medical Unit Head at the Royal Melbourne Hospital (RMH). Spiros received his PhD from the University of Melbourne for his research entitled ‘Latent Autoimmune Diabetes in Adults (LADA): New Clinical, Immunogenetic and Metabolic Perspectives’ completed at the Walter & Eliza Hall Institute. For his post doctoral research he conducted a randomised clinical trial on nasal insulin in adults with autoimmune diabetes. In conjunction with Professor Peter Colman he developed the BioGrid Diabetes Database which is now being used in multiple NADC member institutes in Australia. He established the RMH Bariatric Medicine Clinic and continues to have a keen interest in the clinical management of obesity. Spiros has served on multiple program organising committees for the Australian Diabetes Society Annual Scientific Meeting and also on DART grant review panels. His clinical research interests include investigating adult-onset autoimmune diabetes, obesity and new models of care for hospital diabetes inpatients.
Associate Professor Louise Maple-Brown is Head of Department of Endocrinology, Royal Darwin Hospital and a Principal Research Fellow within the Wellbeing and Preventable Chronic Diseases Division at Menzies School of Health Research, Darwin. Louise leads the clinical research program within that division of Menzies, with a focus on diabetes and related conditions in Indigenous Australians. Louise’s major clinical and research interests are in Indigenous health, rural and remote health, diabetes in pregnancy, type 2 diabetes in youth, renal and cardiovascular complications of diabetes. Currently Louise is the lead investigator on 2 large NHMRC-funded projects: The eGFR study (Accurate assessment and progression of kidney damage in Indigenous Australians) and the Northern Territory Diabetes in Pregnancy Partnership Project. After completing the majority of her physician and endocrinology training at St Vincents Hospital Sydney, Louise moved to Darwin in 2002 to pursue her passion for improving the health of Indigenous Australians. Louise has been on the Council of the Australasian Diabetes in Pregnancy Society (ADIPS) since 2012 and is actively involved in peer review of research, including as a member of NHMRC grant review panel and Diabetes Australia Research Trust Research Advisory Panel. Louise is involved in teaching, training and mentoring trainees and students across career stages and disciplines, including Aboriginal Health Practitioners, diabetes nurse educators and practitioners, registrars in general practice, public health, internal medicine, endocrinology and obstetrics and gynaecology. (Director Disclosures - PDF)
Professor Josephine Forbes is an NHMRC Senior Research Fellow, Head of the Glycation and Diabetes Group and Cardiometabolic Programs at Mater Research Institute – The University of Queensland. Josephine conducts both basic and clinical research where her special interests lie in diabetes complications including nephropathy and in the pathogenesis of type 1 diabetes. Her research has attracted awards such as the Commonwealth Health Minister’s Award for Excellence in Health and Medical Research and an NHMRC Achievement Award. She has a strong commitment to the development of young researchers and in bridging the gaps between clinical and basic research by bringing together multidisciplinary teams. Josephine is also an advocate of community based programs providing education and opportunities to be involved in health research to the general public including to school aged participants. She completed her PhD in Melbourne at the Royal Children’s Hospital in 2000 followed by post-doctoral studies at the Austin Hospital (Dept of Medicine, University of Melbourne) and then the Baker IDI Heart and Diabetes Institute in Melbourne. Josephine sits on a number of panels including the JDRF Australia Professional Advisory Panel and serves on grant review panels both within Australia (eg NHMRC, DART) and internationally (eg JDRF, DVA, MRC). (Director Disclosures - PDF)
Professor Richard MacIsaac is a clinician researcher who is currently director of Endocrinology and Diabetes at St Vincent’s Hospital Melbourne and the University of Melbourne.He has published over 250 research articles. Currently specific research interests include inpatient glycaemic control, defining the albuminuria and glomerular filtration rate relationship in diabetes, investigating new biomarkers for renal and vascular disease in diabetes and studying renal function in indigenous Australians. He also has an interest in the application of new medicines and technologies to improve glycaemic control and outcomes in people with diabetes. He is currently a council member of the Australian Diabetes Society. His clinical practice includes a mixture of public and private outpatients and inpatient work.
Professor Christopher (Chris) Nolan is a clinician/scientist/teacher/policy advisor in diabetes. He completed his training in Medicine at the University of Melbourne (BMedSc and MBBS-1983) and Endocrinology at The Royal Melbourne Hospital (FRACP-1991). He received his doctoral degree from the University of Melbourne on glucose metabolism and insulin action in pregnancy under the supervision of Prof Joe Proietto (1998). He received further training in islet beta-cell research at the University of Montreal under supervision of Prof Marc Prentki (2002-4). He moved to Canberra to join the Endocrinology Department at The Canberra Hospital and the ANU Medical School in 2005. He is currently Associate Dean of Research and Professor of Endocrinology for the ANU Medical School, Chair of the ANU College of Health and Medicine Research Committee, and a Senior Staff Specialist in Endocrinology at Canberra Health Services. In 2018 he stepped down as Director of Diabetes Services (2011-2018) and Director of Endocrinology (2016-2018) at the Canberra Hospital. Under his leadership, the ACT Health Diabetes Service was recognised as a National Centre of Excellence by the National Association of Diabetes Centres. Prof Nolan is currently a Board Member of the Australian Diabetes Society and Co-Chair of the Advisory Committee of the Diabetes Australia Research Program. He has previously been President of the Australasian Diabetes in Pregnancy Society and Council Member of the International Association of Diabetes in Pregnancy Study Groups. He is an Advisory Board Member for Diabetologia (2020-) and an International Review Panel Member for the Danish Diabetes Academy Committee for Talent Development (2018-). He directs an active diabetes research laboratory at the John Curtin School of Medical Research focusing on islet beta-cell failure in type 1 and 2 diabetes and the role of insulin hypersecretion in metabolic syndrome and related conditions. He is involved in multicentre diabetes clinical studies including the NHMRC funded Treatment of Booking Gestational Diabetes (TOBOGM) study. He is a lead investigator for the ANU Grand Challenge project, Our Health in Our Hands, which includes research into improving the care of people with type 1 diabetes using a personalised medicine approach.
Professor Jerry Greenfield is an Endocrinologist and clinical diabetes researcher. He is Head, Department of Endocrinology, and Director, Diabetes Services, St Vincent's Hospital (Sydney). Under his direction, the Diabetes Service obtained a National Association of Diabetes Centres (NADC) Centre of Excellence award in 2019. He undertook his PhD at the Garvan Institute (2001-2004) and a post-doctoral fellowship at the University of Cambridge, Addenbrooke’s Hospital, United Kingdom (2005-2006). His other current positions and roles include: Clinical Associate Dean, St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney; Laboratory Head, Clinical Diabetes, Appetite and Metabolism, Garvan Institute of Medical Research; Editor-in-Chief, Endocrinology, Diabetes and Metabolism Case Reports; and Editorial Board member, Clinical Obesity. His recent research interests focus on elucidating the molecular basis of insulin resistance by studying humans with insulin-sensitive obesity. He was awarded a Diabetes Australia Millennium Grant in 2019 to undertake a study of the effects of metformin on insulin resistance in type 1 diabetes. He is currently heading a study of antibody-negative type 1 diabetes to elucidate the aetiology of insulin deficiency in individuals with apparent non-immune type 1 diabetes. Finally, he oversees a precision medicine program aimed at determining the ‘omic’ factors that predict maximal effectiveness and safety of diabetes medications in an individual.
Melkam Kebede was awarded her Ph.D. in 2007 from the University of Melbourne. During this period, she studied the metabolic consequences of pancreatic β-cell specific overexpression of fructose- 1,6-bisphosphatase using a transgenic mouse model, under the supervision of Professor Joseph Proietto and A/Prof Sof Andrikopoulos. In 2007 Melkam moved to Canada to undertake postdoctoral training at Montreal Diabetes Research Centre where she worked to characterize and understand the regulation and role of the G protein coupled receptor, GPR40 in pancreatic β-cells - under the mentorship of Professor Vincent Poitout. In Montreal, Melkam was supported by a post-doctoral fellowship from the Canadian Diabetes Association. In 2012 Melkam joined Professor Alan Attie’s laboratory at the University of Wisconsin, Madison for her second post-doctoral fellowship. In the Attie laboratory Melkam studied the involvement of VPS10 family of proteins, specifically Sorcs1, in the formation and stability of insulin containing secretory granules in pancreatic β-cells. Her research at the University of Wisconsin was supported by the American Diabetes Association mentor based post-doctoral fellowship. In 2015, Melkam returned to Australia to establish her own independent career as a Laboratory Head at the Charles Perkins Centre, University of Sydney funded by a Philanthropic Fellowship from the University of Sydney. Her lab aims to understand the mechanisms of β-cell failure in the pathogenesis of type 2 diabetes. Her research in Sydney has been funded by Diabetes Australia Research Trust and the NHMRC project and Ideas grants.
A/Professor Sof Andrikopoulos is the Chief Executive Officer and Past President of the Australian Diabetes Society. A/Professor Andrikopoulos is a NH&MRC Senior Research Fellow/Associate Professor and Head of the Islet Biology and Metabolism Research Group at the University of Melbourne, Department of Medicine (Austin Health), investigating the genetic susceptibility of islet dysfunction using animal models of diabetes. This research has led to the hypothesis that increased insulin secretory demand may be a mechanism that contributes to diabetes and that strategies that promote metabolic deceleration may be beneficial. This has clinical implications since a common class of drug used to treat patients with Type 2 diabetes causes increased insulin secretion and in fact may be detrimental in the long term. A/Professor Andrikopoulos has had grant support from the NH&MRC since 2000, is Editor-In-Chief of the Journal of Endocrinology/Journal of Molecular Endocrinology, and was on the editorial board of Journal of Nutrition, Molecular and Cellular Endocrinology and the Journal of Diabetes and its Complications, on the JDRF/Australia Islet Transplantation Program Advisory Committee, has served on NH&MRC Grant Review Panels and the NH&MRC Academy and regularly reviews manuscripts for leading journals in the field including Diabetes and Diabetologia. A/Professor Andrikopoulos is the current Chief Executive Officer of the Australian Diabetes Society. A/Professor Andrikopoulos was awarded a NH&MRC Award for Research Excellence in 2008 and a Diabetes Australia Research Trust Millennium Award in 2010.
Ms Linda Valenzisi is the Business & Events Manager for the Australian Diabetes Society (ADS). Linda also provides administrative support to the National Association of Diabetes Centres (NADC) and Diabetic Foot Australia (DFA). Linda has worked with the ADS for over 14 years and is one or the organisation's greatest assets. Linda’s background is in travel and tourism, business administration and event management. She supports many aspects of the busy secretariat including memberships, finance, website, newsletters, marketing and promotions, event management and support to the executive council.
View past ADS council members.